Pneumococcal vaccines protect against the diseases caused by types of “pneumococcus”. The bacteria called “pneumococcus” form a group of more than 100 slightly different types of bacteria. Some of them can cause an ear, sinus or lung infections. In some other cases, they can cause a blood or lining of the brain and spinal cord infections. Many people carry the bacteria and do not become ill. It is also possible that a person carrying the bacteria transmits it to a more vulnerable person. The bacteria can be spread by kissing, sneezing, or sharing drinks. Young children, elderly people, or people having certain medical conditions are the most vulnerable. The pneumococcal vaccine currently prescribed in the US is called Prevnar 20™. Prevnar 20™ protects against 20 types of pneumococcus.
Doctors at National Clinical Research are researching a new investigational pneumococcal vaccine that aims to protect against more types of pneumococcus. The CDC recommends children receive routine vaccinations for pneumococcal at 2, 4, 6, and 12 to 15 months of age. If you choose to participate in this study, your child will receive the investigational pneumococcal vaccine or Prevnar 20 as part of their routine vaccinations.
42 to 89 days old
- Have not received any vaccinations for pneumococcal
7 office visits; 4 phone calls over 19 months
You may be reimbursed up to $425 for your participation.
Want to participate? Fill out the interest form! Click to Call Us!